These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Current and Emerging Treatment Modalities for Leber's Hereditary Optic Neuropathy: A Review of the Literature. Theodorou-Kanakari A; Karampitianis S; Karageorgou V; Kampourelli E; Kapasakis E; Theodossiadis P; Chatziralli I Adv Ther; 2018 Oct; 35(10):1510-1518. PubMed ID: 30173326 [TBL] [Abstract][Full Text] [Related]
5. Treatment of Leber's hereditary optic neuropathy: An overview of recent developments. Zuccarelli M; Vella-Szijj J; Serracino-Inglott A; Borg JJ Eur J Ophthalmol; 2020 Nov; 30(6):1220-1227. PubMed ID: 32552047 [TBL] [Abstract][Full Text] [Related]
6. Long-term outcomes of gene therapy for the treatment of Leber's hereditary optic neuropathy. Yang S; Ma SQ; Wan X; He H; Pei H; Zhao MJ; Chen C; Wang DW; Dong XY; Yuan JJ; Li B EBioMedicine; 2016 Aug; 10():258-68. PubMed ID: 27426279 [TBL] [Abstract][Full Text] [Related]
7. Leber's hereditary optic neuropathy - Case report. Iorga RE; Mihailovici R; Ozturk MR; Costin D Rom J Ophthalmol; 2018; 62(1):64-71. PubMed ID: 29796436 [TBL] [Abstract][Full Text] [Related]
8. Dominant Optic Atrophy and Leber's Hereditary Optic Neuropathy: Update on Clinical Features and Current Therapeutic Approaches. Chun BY; Rizzo JF Semin Pediatr Neurol; 2017 May; 24(2):129-134. PubMed ID: 28941528 [TBL] [Abstract][Full Text] [Related]
9. Mitochondrial replacement in an iPSC model of Leber's hereditary optic neuropathy. Wong RCB; Lim SY; Hung SSC; Jackson S; Khan S; Van Bergen NJ; De Smit E; Liang HH; Kearns LS; Clarke L; Mackey DA; Hewitt AW; Trounce IA; Pébay A Aging (Albany NY); 2017 Apr; 9(4):1341-1350. PubMed ID: 28455970 [TBL] [Abstract][Full Text] [Related]
10. Idebenone protects against retinal damage and loss of vision in a mouse model of Leber's hereditary optic neuropathy. Heitz FD; Erb M; Anklin C; Robay D; Pernet V; Gueven N PLoS One; 2012; 7(9):e45182. PubMed ID: 23028832 [TBL] [Abstract][Full Text] [Related]
12. Leber's hereditary optic neuropathy: a multifactorial disease. Yen MY; Wang AG; Wei YH Prog Retin Eye Res; 2006 Jul; 25(4):381-96. PubMed ID: 16829155 [TBL] [Abstract][Full Text] [Related]
13. Emerging Mitochondrial Therapeutic Targets in Optic Neuropathies. Lopez Sanchez MI; Crowston JG; Mackey DA; Trounce IA Pharmacol Ther; 2016 Sep; 165():132-52. PubMed ID: 27288727 [TBL] [Abstract][Full Text] [Related]
14. Pathophysiology of Conversion to Symptomatic Leber Hereditary Optic Neuropathy and Therapeutic Implications: a Review. Mejia-Vergara AJ; Seleme N; Sadun AA; Karanjia R Curr Neurol Neurosci Rep; 2020 Apr; 20(5):11. PubMed ID: 32296973 [TBL] [Abstract][Full Text] [Related]
15. Oestrogens ameliorate mitochondrial dysfunction in Leber's hereditary optic neuropathy. Giordano C; Montopoli M; Perli E; Orlandi M; Fantin M; Ross-Cisneros FN; Caparrotta L; Martinuzzi A; Ragazzi E; Ghelli A; Sadun AA; d'Amati G; Carelli V Brain; 2011 Jan; 134(Pt 1):220-34. PubMed ID: 20943885 [TBL] [Abstract][Full Text] [Related]
16. Solutions to a Radical Problem: Overview of Current and Future Treatment Strategies in Leber's Hereditary Opic Neuropathy. Spiegel SJ; Sadun AA Int J Mol Sci; 2022 Oct; 23(21):. PubMed ID: 36361994 [TBL] [Abstract][Full Text] [Related]
17. The Progress of Gene Therapy for Leber's Optic Hereditary Neuropathy. Zhang Y; Tian Z; Yuan J; Liu C; Liu HL; Ma SQ; Li B Curr Gene Ther; 2017; 17(4):320-326. PubMed ID: 29189152 [TBL] [Abstract][Full Text] [Related]
18. Pathologically Responsive Mitochondrial Gene Therapy in an Allotopic Expression-Independent Manner Cures Leber's Hereditary Optic Neuropathy. Wang Y; Hu LF; Cui PF; Qi LY; Xing L; Jiang HL Adv Mater; 2021 Oct; 33(41):e2103307. PubMed ID: 34431574 [TBL] [Abstract][Full Text] [Related]
19. Increased Protein Zhou L; Chan JCY; Chupin S; Gueguen N; Desquiret-Dumas V; Koh SK; Li J; Gao Y; Deng L; Verma C; Beuerman RW; Chan ECY; Milea D; Reynier P Int J Mol Sci; 2020 Apr; 21(8):. PubMed ID: 32344771 [TBL] [Abstract][Full Text] [Related]
20. Mesenchymal stem cells (MSCs) in Leber's hereditary optic neuropathy (LHON): a potential therapeutic approach for future. Subramaniam MD; Chirayath RB; Iyer M; Nair AP; Vellingiri B Int Ophthalmol; 2022 Sep; 42(9):2949-2964. PubMed ID: 35357640 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]